| Literature DB >> 30587122 |
Priscila R Guerra1, Ana Herrero-Fresno1, Victor Ladero2, Begoña Redruello2, Teresa Pires Dos Santos1, Malene R Spiegelhauer1, Lotte Jelsbak3, John Elmerdahl Olsen4.
Abstract
BACKGROUND: Avian pathogenic Escherichia coli (APEC) is the infectious agent of a wide variety of avian diseases, which causes substantial economic losses to the poultry industry worldwide. Polyamines contribute to the optimal synthesis of nucleic acids and proteins in bacteria. The objectives of this study were to investigate; i) whether APEC E. coli encodes the same systems for biosynthesis and uptake as described for E. coli K12 and ii) the role of polyamines during in vitro growth of an avian pathogenic E. coli strain (WT-ST117- O83:H4T).Entities:
Keywords: APEC; E. coli; Fitness; Gene expression; Membrane stress; Polyamines; UHPLC; Virulence
Mesh:
Substances:
Year: 2018 PMID: 30587122 PMCID: PMC6307189 DOI: 10.1186/s12866-018-1355-9
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Graphic representation of putrescine/spermidine biosynthesis pathways and transport systems a) putrescine/spermidine biosynthesis, where the deleted genes in the present study are indicated by an asterisk; b) putrescine/spermidine main transport systems, where ‘p’ represents putrescine and ‘s’ represents spermidine c) graphic representation of putrescine/proton symporter and putrescine/ornithine antiporter, where ‘p’ represents putrescine and ‘o’ represents ornithine. The figure is revised from Shah (20) and BioCyc (https://biocyc.org); SAM: S-adenosylmethionine; Decarbox. SAM: Decarboxylated SAM
Main genomic features of the APEC strain E. coli ST117
| Genome size | 5,028,456 bp | |||
| Number of coding sequences | 4840 | |||
| Number of contigs (with PEGs) | 135 | |||
| GC % | 50.4% | |||
| R-genes (genotype) | V-genes (genotype) | Replicons | MLST-type | Serotype |
| IncFIB | ST117 | O83:H4 |
Fig. 2Growth phenotypes of polyamine biosynthesis mutants of E.coli-ST117 in a) M9-minimal medium; b) M9-minimal medium supplemented with putrescine; c) M9-minimal medium supplemented with spermidine
Growth rates of selected polyamine biosynthesis and transport system mutants
| Growth condition | Growth rate | ||
|---|---|---|---|
| WT-ST117 | Δ | Δ | |
| M9 minimal medium | 0.52 ± 0.04 | 0.27 ± 0.02a** | 0.26 ± 0.00a** |
| M9 + putrescine | 0.46 ± 0.02 b* | 0.46 ± 0.01 b* | 0.37 ± 0.01a**,b* |
| M9 + spermidine | 0.42 ± 0.01 b** | 0.44 ± 0.06 b* | 0.43 ± 0.02 b* |
| M9 + ornithine | 0.41 ± 0.01 b* | 0.30 ± 0.01 a** | 0.41 ± 0.01 b* |
| M9+ arginine | 0.47 ± 0.00 b* | 0.40 ± 0.01a*,b* | 0.28 ± 0.06a** |
agrowth rates marked with a are significantly different from the growth rate of WT-ST117 growing at the same condition; mean values ± standard deviation
bgrowth rates marked with b are significantly different from the growth rate of the same strain growing in M9 minimal medium without supplementation; mean values ± standard deviation; *p < 0.05;** p < 0.01
Fig. 3Growth phenotypes of polyamine transport mutants of E.coli WT-ST117 in a) M9-minimal medium; b) M9-minimal medium supplemented with putrescine; c) M9-minimal medium supplemented with spermidine
Fig. 4Growth phenotypes of polyamine biosynthesis and transport mutants of E.coli WT-ST117 in a) M9-minimal medium supplemented with ornithine; b) M9-minimal medium supplemented with arginine
Fig. 5Intracellular putrescine concentration in the strain E.coli WT-ST117 and the mutant ΔpotE-ST117 in different media a) M9-minimal medium; b) M9-minimal medium supplemented with putrescine
Fig. 6Intracellular putrescine concentration in the strain E.coli WT-ST117 and the mutant ΔspeB/C-ST117 in different medium a) M9-minimal medium; b) M9-minimal medium supplemented with putrescine; *** p < 0.001
Fig. 7Growth of WT-ST117, ΔpotE-ST117, and ΔpotE/pACYC184 strains in the presence of 0.1% (w/v) SDS; *** p < 0.001
Strains and plasmids used in the study
| Strains and plasmids | Relevant featuresa,b | Reference |
|---|---|---|
| | Virulent reference strain, APEC strain | [ |
| MG1655 | MG1655/K-12- Reference strain | ATCC 2592 |
| | Cloning intermediate strain | Termo Scientific |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Δ | This work | |
| Plasmids | ||
| pKD46 | Plasmid with λ-Red recombinase expressed from arabinose inducible promoter | [ |
| pKD3 | Template plasmid for λ -red mutagenesis, ChlR, AmpR | Termo Scientific |
| pJET 1.2 | Cloning vector, AmpR | Termo Scientific |
| pACYC184 | Expressing the Δ | Termo Scientific |
| pM3224T | Template plasmid for TmpR | [ |
aThe metabolic pathway affected for each mutant is indicated in Fig. 1
bChlR chloramphenicol resistant; TetR tetracycline resistant; GenR gentamicin resistant; TmpR trimethoprim resistant; AmpR ampicillin resistant